Paper Details

  1. Home
  2. Paper Details

Pirbuterol, a selecttve beta2 adrenergic bronchodilator.

Author: BarthW E, ConstantineJ W, MooreP F

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Pirbuterol, a new beta2 adrenergic agonist bronchodilator, was found to be more selective for pulmonary tissue than salbutamol and isoproterenol, and effective by oral, intravenous, and inhalation routes of administration.
Paper Details　
Original Abstract of the Article :
Pirbuterol, 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-tert-butylaminoethyl)pyridine, is a new beta2 adrenergic agonist bronchodilator. Comparison of the relative potencies of pirbuterol, salbutamol and isoproterenol as relaxants of isolated guinea-pig tracheal muscle and as positive chronotropic agen...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/712629

データ提供：米国国立医学図書館（NLM）

Pirbuterol: A Breath of Fresh Air for Asthma

This research delves into the [pharmacological properties] of [pirbuterol], a [selective beta2 adrenergic bronchodilator] for the treatment of [asthma]. The authors compared the [efficacy and selectivity] of [pirbuterol] to [salbutamol and isoproterenol], two other [beta2 agonists]. The study found that [pirbuterol] exhibited [superior selectivity for pulmonary tissue] over [cardiac tissue], suggesting [fewer cardiovascular side effects] compared to other [beta2 agonists].

Selective Bronchodilation: A Targeted Approach

This research highlights the potential of [pirbuterol] to provide [effective bronchodilation] while [minimizing cardiovascular risks]. This finding is significant because [selective beta2 agonists] can offer [a safer and more targeted approach] to [managing asthma symptoms].

Asthma: A Breath of Hope

This study reminds us that [asthma] is a chronic condition that requires [ongoing management]. It highlights the importance of [choosing the right medication] to [effectively control symptoms] and [improve quality of life].

Dr. Camel's Conclusion

This research offers valuable insights into the pharmacological profile of [pirbuterol] and its potential as a [safe and effective treatment] for [asthma]. As a researcher, I am always inspired by the ongoing quest for [better therapies] to improve the lives of those living with [chronic conditions]. This study showcases the remarkable progress in [respiratory medicine] and the promise of [selective beta2 agonists] to offer [a more targeted and effective approach] to [managing asthma].

Date :
  1. Date Completed 1979-01-26
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

712629

DOI: Digital Object Identifier

712629

Related Literature

Article Analysis
・Effects of pirbuterol acetate oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.